Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juričević, Mirjana"'
Autor:
Radić Antolic, Margareta, Boban, Ana, Zadro, Renata, Juričević, Mirjana, Sučić, Mirna, Bašić-Kinda, Sandra, Labar, Boris
Myeloproliferative disorders share clinical and biological similarities that may be influenced by presence of recently discovered point mutation in JAK2 gene (JAK2 V617F). The aim of this study was to determine the correlation between JAK2 V617F muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::df3d918432c88b5a530eefb4da7b8824
https://www.bib.irb.hr/302311
https://www.bib.irb.hr/302311
Autor:
Radić Antolic, Margareta, Zadro, Renata, Juričević, Mirjana, Bašić-Kinda, Sandra, Labar, Boris
Mijeloproliferativne bolesti obuhvaćaju skupinu poremećaja karakteriziranih sličnim kliničkim slikama te klonalnom proliferacijom jedne ili više staničnih loza, što je posljedica transformacije na razini pluripotentne matične stanice. Toj sku
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::3e4e24c2edab18b4ffb004093965e4fd
https://www.bib.irb.hr/263357
https://www.bib.irb.hr/263357
Autor:
Radić Antolic, Margareta, Sučić, Mirna, Zadro, Renata, Davidović-Mrsić, Sanja, Marković-Glamočak, Mirjana, Ries, Sunčica, Gjadrov-Kuvezdić, Koraljka, Vrbanus, Ljiljana, Batinić, Drago, Dubravčić, Klara, Juričević, Mirjana, Labar, Boris
Background: Chronic myelogenous leukemia (CML) is a myeloproliferative disease with t(9 ; 22) and/or BCR/ABL fusion gene. One of treatment options for CML patients is inhibition of BCR/ABL and c-kit (CD117) tyrosine kinase activity with imatinib mesy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::ecd79da06fb8b3c7ba09915a9712484d
https://www.bib.irb.hr/253870
https://www.bib.irb.hr/253870
Autor:
Sučić, Mirna, Davidović-Mrsić, Sanja, Marković-Glamočak, Mirjana, Ries, Sunčica, Gjadrov-Kuveždić, Koraljka, Vrbanus, Ljiljana, Zadro, Renata, Batinić, Drago, Dubravčić, Klara, Juričević, Mirjana, Labar, Boris
Chronic myelogenous leukemia (CML) is a myeloproliferative disease with t(9 ; 22) and/or BCR/ABL fusion gene. Treatment of CML patients with imatinib mesylate (Gleevec) is based on the inhibition of BCR/ABL and c-kit (CD117) tyrosine kinase activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::693e0ab1bf7c54ec3b3ac2b1bece040b
https://www.bib.irb.hr/218592
https://www.bib.irb.hr/218592
The goal for a modern hematology instrument, besides the precise blood cell count, is to eliminate the need for technical review and microscopy in differential blood analysis. The aim of our study was to evaluate the differential performance of three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::7727635da263f43b8f0c6974eca4d418
https://www.bib.irb.hr/208472
https://www.bib.irb.hr/208472
Autor:
Leniček Krleža, Jasna, Zadro, Renata, Nakić, Melita, Sučić, Mirna, Huzjak, Nevenka, Juričević, Mirjana, Stavljenić-Rukavina, Ana
Važnost broja trombocita u cirkulaciji proizlazi iz njihove višestruke uloge u procesu hemostaze. Rutinska pretraga kompletne krvne slike danas uključuje osim broja trombocita i trombocitne pokazatelje (indekse) te grafički prikaz njihove raspodj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9d1330d8b02bb726593b3b583dd45942
https://www.bib.irb.hr/290043
https://www.bib.irb.hr/290043